Friday, December 5, 2025

FDA awards Mindbreeze InSpire Software Licenses contract

Mindbreeze has been awarded a 2-year $4M contract for its InSpire Software Licenses by the Food and Drug Administration. The contract was awarded using the GSA FSS.

Mindbreeze InSpire promises to connect all information from throughout the entire digital workplace and provides personalized views that support each different department.

Awardee Name: MINDBREEZE CORPORATION
Contract Duration: 24 months
Total Contract Value: $3,571,563.06
Action Obligation: $1,190,521.02
Funding Agency: FOOD AND DRUG ADMINISTRATION
Number of Bidders: 1
Award ID: 75F40120F80263

[related-post]

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Innovation in Action: Advancing Government Health with Philips

FORUM is proud to partner with Philips for a series of articles on their groundbreaking innovations in health technology that serve public- and private sector citizens and service members. Please take a look to learn more about how Philips is advancing modern and efficient health care, while improving lives for generations to come.

Don’t Miss A Thing

Jackie Gilbert
Jackie Gilbert
Jackie Gilbert is a Content Analyst for FedHealthIT and Author of 'Anything but COVID-19' on the Daily Take Newsletter for G2Xchange Health and FedCiv.

Subscribe to our mailing list

* indicates required